IRGIX | MGLMX | IRGIX / MGLMX | |
Total Expense Ratio | 0.90 | 0.94 | 96% |
Annual Report Gross Expense Ratio | 1.06 | 0.95 | 112% |
Fund Existence | 19 years | 10 years | - |
Gain YTD | 1.400 | -0.187 | -749% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 140M | 2.23B | 6% |
Annual Yield % from dividends | 3.15 | 2.60 | 121% |
Returns for 1 year | 4.74 | 1.09 | 435% |
Returns for 3 years | -3.57 | -9.34 | 38% |
Returns for 5 years | 22.86 | 21.00 | 109% |
Returns for 10 years | 13.83 | 15.53 | 89% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GOOY | 12.28 | 0.05 | +0.41% |
YieldMax GOOGL Option Income Stgy ETF | |||
FBT | 160.84 | N/A | N/A |
First Trust NYSE Arca Biotech ETF | |||
GVIP | 129.00 | N/A | N/A |
Goldman Sachs Hedge Industry VIP ETF | |||
QDIV | 33.47 | N/A | N/A |
Global X S&P 500® Quality Dividend ETF | |||
EMXC | 59.37 | -0.23 | -0.39% |
iShares MSCI Emerging Mkts ex China ETF |